Stock A142280 GREEN CROSS MEDICAL SCIENCE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Green Cross Medical Science Corporation

Equities

A142280

KR7142280007

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-13 EDT 		5-day change 1st Jan Change
4,070 KRW 0.00% Intraday chart for Green Cross Medical Science Corporation -0.12% -14.68%
2023 Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors
CI
Green Cross Medical Science Corporation announced that it expects to receive KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors
CI
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea
CI
Hemotune AG announced that it has received CHF 5.1 million in funding from Green Cross Medical Science Corporation, ZKB Start-up Finance, Occident Group AG
CI
Green Cross Medical Science Enters into Co-Development Agreement with GeneCast to Develop A New COVID-19 Detection Kit
CI
GreenCross Medical Science Corp. cancelled the acquisition of additional 29.54% stake in CERAGEM Medisys, Inc.
CI
GreenCross Medical Science Corp. agreed to acquire additional 29.54% stake in CERAGEM Medisys, Inc for KRW 4.6 billion.
CI
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from KB Securities Co., Ltd., Investment Arm and other investors
CI
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors
CI
GreenCross Medical Science Corp. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors
CI
GreenCross Medical Science Corp. announced that it expects to receive funding from KB Securities Co., Ltd., Investment Arm and other investors
CI
Tranche Update on GreenCross Medical Science Corp.'s Equity Buyback Plan announced on March 2, 2017.
CI
GreenCross Medical Science Corp.'s Equity Buyback announced on March 2, 2017 has closed with 50,000 shares, representing 0.52% for KRW 536.95 million.
CI
GreenCross Medical Science Corp. announces an Equity Buyback for 50,000 shares.
CI
GreenCross Medical Science Corp. authorizes a Buyback Plan.
CI
GreenCross Medical Science Corp. completed the acquisition of 21.06% stake in CERAGEM Medisys, Inc.
CI
GreenCross Medical Science Corp. agreed to acquire a 21.06% stake in CERAGEM Medisys, Inc. for KRW 5 billion.
CI
GreenCross Medical Science Corp. has completed an IPO in the amount of KRW 12.00 billion.
CI
GreenCross Medical Science Corp. has filed an IPO in the amount of KRW 11.20 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A142280 Stock
  4. News Green Cross Medical Science Corporation